Introduction {#tca13493-sec-0005}
============

Computed tomography (CT) is effective for screening patients at a high risk of lung cancer, increasing the likelihood of identifying a solitary pulmonary nodule.[1](#tca13493-bib-0001){ref-type="ref"}, [2](#tca13493-bib-0002){ref-type="ref"}, [3](#tca13493-bib-0003){ref-type="ref"} After assessment of the probability of malignancy, when clinical pretest probability and radiological findings are discordant or the probability of malignancy is low to moderate, a non‐surgical biopsy such as a transbronchial biopsy or a transthoracic needle biopsy is considered to proceed to definitive management.[4](#tca13493-bib-0004){ref-type="ref"}, [5](#tca13493-bib-0005){ref-type="ref"}, [6](#tca13493-bib-0006){ref-type="ref"}, [7](#tca13493-bib-0007){ref-type="ref"} However, when in relation to the size and location of the nodule, tissue harvesting may be unsuitable. A surgical biopsy is considered if false‐negative results are still suspected after a non‐surgical biopsy or performing a non‐surgical biopsy would expose the patient to unnecessary risks or inadequately lengthen surgical management.[4](#tca13493-bib-0004){ref-type="ref"}, [5](#tca13493-bib-0005){ref-type="ref"}

For patients with a lung nodule without a preoperative tissue diagnosis, radical surgery, generally lobectomy, is often performed after a diagnosis of malignancy from intraoperative frozen section analysis (FSA), with the tissue specimen obtained by wedge resection or needle biopsy.[8](#tca13493-bib-0008){ref-type="ref"}, [9](#tca13493-bib-0009){ref-type="ref"} Nevertheless, a considerable problem remains because of the 2%--13% false‐negative rate using FSA[9](#tca13493-bib-0009){ref-type="ref"}, [10](#tca13493-bib-0010){ref-type="ref"} and the potential risk for tumor dissemination in cases with a positive margin after wedge resection or needle biopsy.[11](#tca13493-bib-0011){ref-type="ref"}, [12](#tca13493-bib-0012){ref-type="ref"} A few studies have reported initial definitive radical surgery in the absence of tissue diagnosis as an option for selected patients, reducing cost and shortening operative time and length of hospital stay.[13](#tca13493-bib-0013){ref-type="ref"}, [14](#tca13493-bib-0014){ref-type="ref"}, [15](#tca13493-bib-0015){ref-type="ref"} However, it remains unclear whether it is acceptable to proceed to definitive lobectomy (DL) without intraoperative FSA.

Therefore, the aim of our study was to clarify whether DL could be an acceptable treatment option in selected cases by evaluation of diagnostic accuracy of clinical and frozen section diagnosis among patients who underwent DL or wedge resection for FSA.

Methods {#tca13493-sec-0006}
=======

Patients and data collection {#tca13493-sec-0007}
----------------------------

We retrospectively reviewed the medical records of consecutive patients who underwent lung resection without a preoperative tissue diagnosis between January 2014 and December 2018 at the Jikei University Hospital in Tokyo, Japan. Of these, patients who underwent DL or wedge resection for FSA with intended follow‐up lobectomy were potential cases for our study, and we excluded patients with coexisting or a past‐history of other malignancy, including lung malignancy (with the intention of eliminating the possibility of metastatic lung tumors), and those who underwent pneumonectomy, bilobectomy, segmentectomy, wedge resection without intraoperative FSA, and surgery without curative intent (with the intention to evaluate definitive resection without FSA in lobectomy performed most frequently as a radical resection).

The clinical diagnosis was based on a comprehensive review of the clinical information, clinical course, radiological findings (spiculation, pleural indentation, shape of the nodule, ground‐glass nodule \[GGN\], and calcification pattern), chronological evaluation of radiological findings at multiple times including tumor doubling time, and fluorodeoxyglucose‐positron emission tomography (FDG‐PET). Patients were selected based on the degree of certainty of ensuring a safe margin for wedge resection and on the probability of malignancy. They were subsequently assigned to the group of candidates either for DL or for wedge resection for FSA according to our surgical treatment algorithm for lung nodules without preoperative tissue diagnosis (Fig [1](#tca13493-fig-0001){ref-type="fig"}).

![Surgical treatment algorithm for lung nodules without preoperative tissue diagnosis.](TCA-11-1996-g001){#tca13493-fig-0001}

Clinical demographic and perioperative information and pathological diagnosis were included in the analysis using the following variables collected from the medical records and our prospective database: age, sex, smoking history, radiological findings of lung CT and FDG‐PET, any preoperative biopsy, preoperative clinical diagnosis, clinical stage, the result of frozen section diagnosis, number of stapler cartridges used during the wedge resection, margins of the wedge resection, operative time for wedge resection and FSA, surgical approach and procedure, final pathological diagnosis and stage, total operative time, and postoperative complications. From CT findings, types of nodules were classified as pure GGN, part‐solid GGN, or solid nodule. The malignant probability score, which is applicable to cases with solid nodules, reported by Herder *et al*. was calculated by variables of age, smoking, history of extrathoracic cancer, tumor diameter, existence of spiculation, tumor located in the upper lobe, and the results of FDG‐PET.[^16^](#tca13493-bib-0016){ref-type="ref"} This scoring method incorporating FDG‐PET as a variable was reported to be more reliable than other scoring methods. Clinical and pathological staging were classified according to the eighth edition of the TNM Classification of Malignant Tumors.

Informed consent was obtained from all patients for treatment, after explaining the surgical indication for DL and wedge resection for FSA with intended follow‐up lobectomy, the associated risks and benefits. All procedures were performed in accordance with the ethical standards of the Ethics Committee of Jikei University School of Medicine (date: 13 May 2019, approval number: 31‐015\[9514\]), and the Declaration of Helsinki and its later amendments. The need for obtaining individual patient consent was waived due to the retrospective design of the study.

Statistical analysis {#tca13493-sec-0008}
--------------------

We compared demographics, perioperative outcomes (including operative time, rate of postoperative complications, and length of postoperative hospital stay), and pathological diagnoses between the DL and FSA groups using Fisher\'s exact test or Mann‐Whitney U test as appropriate for the data type and distribution. Perioperative outcomes of wedge resection without lobectomy in cases of benign frozen section diagnosis were excluded from the analysis to eliminate the effects of the extent of surgical resection. Sensitivity, specificity, accuracy, positive predictive, and negative predictive values were calculated for clinical diagnosis or frozen section diagnosis against the final pathological diagnosis. On a subgroup analysis, these values were also compared between the GGN, including pure and part‐solid and solid nodule groups.

All analyses were performed using JMP (version 13.0.0; SAS Institute, Cary, NC, USA), and a *P*‐value \< 0.05 was considered statistically significant.

Results {#tca13493-sec-0009}
=======

In total, 818 patients underwent lung resection between January 2014 and December 2018 at our institute. Of these, 199 patients without preoperative tissue diagnosis met our selection criteria and were included in our analysis: 141 in the DL group and 58 in the FSA group. Table [1](#tca13493-tbl-0001){ref-type="table"} shows individual reasons of the patients assigned to the DL group according to our surgical treatment algorithm. Fig [2a,b](#tca13493-fig-0002){ref-type="fig"} shows the CT and FDG‐PET scan results of an example case with high malignant probability score in the DL group and Fig [2c](#tca13493-fig-0002){ref-type="fig"} shows the CT scan results of an example case for which preoperative nonsurgical biopsy was unsuitable in the FSA group.

###### 

Individual reasons of 141 patients assigned to definitive lobectomy according to our surgical treatment algorithm for lung nodules without preoperative tissue diagnosis

  Individual reason                                      *n* (%)
  ------------------------------------------------------ ---------
  Assessment for feasibility of wedge resection          
  Not feasible due to nodule size                        6 (4)
  Not feasible due to nodule depth                       64 (45)
  Not feasible due to both of size and depth of nodule   28 (20)
  Assessment for necessity of frozen section analysis    
  Omission because of almost certain malignancy          43 (31)

Seven cases that exceeded the size or depth criteria were not assigned to definitive lobectomy because of the easy location of the nodule to enable wedge resection.

![Computed tomography (CT) scan and fluorodeoxyglucose‐positron emission tomography of an example case with high malignant probability score in the definitive lobectomy group (**a**, **b**) and CT scan of an example case for which preoperative non‐surgical biopsy was unsuitable in the frozen section diagnosis group (**c**).](TCA-11-1996-g002){#tca13493-fig-0002}

Patient characteristics, perioperative information, and pathological diagnoses for each group are shown in Table [2](#tca13493-tbl-0002){ref-type="table"}. Patients in the FSA group had smaller and less deep nodules, a higher rate of solid nodules, a higher rate of no uptake and lower rate of intense uptake on FDG‐PET, a lower malignant probability score, and a lower rate of malignancy on clinical and final pathological diagnosis than those in the DL group. The comparison of perioperative outcomes for patients treated by lobectomy indicated a longer operative time for the FSA than the DL group. In the FSA group, a median of three stapler cartridges was used (standard deviation 1), with a median wedge resection time of 37 minutes (standard deviation 22) and a median time for FSA (from sample submission to reporting of results) of 32 minutes (standard deviation 19). A positive surgical margin, on paraffin section analysis, was identified in five cases, with four of these cases being malignant.

###### 

Patients\' background for the two groups: the definitive lobectomy group and wedge resection for the frozen section analysis with intended follow‐up lobectomy group

                                                                                            Frozen section analysis group (*n* = 58) Definitive lobectomy group (*n* = 141)                         
  ------------------------------------------------ ----------------------- -------------- ------------------------------------------ ---------------------------------------- ---------- ---------- ----------
  Age (years), Median ± SD                                                                                                   67 ± 12                                             68 ± 10              0.821
  Sex                                              Male                                                                           32 \(55\)                                           85 \(60\)       0.529
  Female                                                                   26                                                 \(45\) 56                                           \(40\)            
  Smoking history                                  Yes                                                                            37 \(64\)                                           95 \(67\)       0.625
  No                                                                       21                                                 \(36\) 46                                           \(33\)            
  Radiological findings                            Type of nodule          Solid nodule                                           39 \(67\)                                           78 \(55\)       0.042
  Part‐solid GGN                                   19                      \(33\)                                                 56 \(40\)                                                         
  Pure GGN                                         0                       \(0\)                                                   7 \(5\)                                                          
  Spiculation                                      Yes                     6                                                  \(10\) 20                                           \(14\) 0.644      
  No                                               52                      \(90\)                                                121 \(86\)                                                         
  Diameter, mm (Median ± SD)                       16 ± 8                                                                    24 ± 11                                            \< 0.001            
  Depth, mm (Median ± SD)                          20 ± 9                                                                    34 ± 15                                            \< 0.001            
  Location                                         Upper lobe              26                                                 \(45\) 77                                           \(55\) 0.217      
  Elsewhere                                        32                      \(55\)                                                 64 \(45\)                                                         
  PET                                              Intense uptake                                                                  4 \(7\)                                            31 \(22\)       0.007
  Moderate uptake                                                          12                                                 \(20\) 26                                           \(18\)            
  Faint uptake                                                             16                                                 \(28\) 44                                           \(31\)            
  No uptake                                                                8                                                  \(14\) 4                                             \(3\)            
  No PET study                                                             18                                                 \(31\) 36                                           \(26\)            
  Malignant probability score                      \>65%                                                                          15 \(38\)                                           59 \(76\)      \< 0.001
  5--65%                                                                   16                                                 \(41\) 17                                           \(22\)            
  \<5%                                                                     8                                                  \(21\) 2                                             \(2\)            
  Preoperative non‐surgical biopsy                 Yes                                                                             5 \(9\)                                            28 \(20\)       0.060
  No                                                                       53                                                 \(91\) 113                                          \(80\)            
  Preoperative clinical diagnosis                  Malignancy                                                                     44 \(76\)                                          134 \(95\)      \< 0.001
                                                   Stage 0                                                                         2 \(3\)                                             7 \(5\)      
                                                   Stage 1                                                                        41 \(71\)                                          107 \(76\)     
                                                   Stage 2                                                                         1 \(2\)                                            14 \(10\)     
                                                   Stage 3                                                                         0 \(0\)                                             6 \(4\)      
                                                   Benign                                                                         14 \(24\)                                            7 \(5\)      
  Frozen section diagnosis                         Malignant                                                                      41 \(70\)                                                         
  Equivocal                                                                2                                                   \(4\)                                                                
  Benign                                                                   15                                                 \(26\)                                                                
  Surgical approach                                Thoracoscopic surgery   54                                                 \(93\) 127                                          \(90\) 0.723      
  Convert to thoracotomy                           1                       \(2\)                                                   5 \(4\)                                                          
  Thoracotomy                                      3                       \(5\)                                                   9 \(6\)                                                          
  Procedure                                        Right upper lobectomy   17                                                 \(29\) 54                                           \(38\) \< 0.001   
  Right middle lobectomy                           3                       \(5\)                                                  10 \(7\)                                                          
  Right lower lobectomy                            12                      \(20\)                                                 26 \(19\)                                                         
  Left upper lobectomy                                                     3                                                   \(5\) 23                                           \(16\)            
  Left lower lobectomy                                                     8                                                  \(14\) 28                                           \(20\)            
  Wedge resection                                                          15                                                 \(26\) 0                                             \(0\)            
  Final pathological diagnosis                     Malignancy                                                                     41 \(71\)                                          132 \(94\)      \< 0.001
  Adenocarcinoma                                                           30                                                 \(52\) 101                                          \(72\) \< 0.001   
  Squamous cell carcinoma                          8                       \(14\)                                                 19 \(13\)                                                         
  Neuroendocrine carcinoma                         2                       \(3\)                                                   8 \(6\)                                                          
  Other                                                                    1                                                   \(2\) 4                                             \(3\)            
  Benign                                                                   17                                                 \(29\) 9                                             \(6\)            
  Operative time (minutes), Median, SD                                                                                      265 ± 52                                            228 ± 63              0.002
  Postoperative complication                       Yes                                                                             7 \(16\)                                           31 \(22\)       0.521
  No                                                                       36                                                 \(84\) 110                                          \(78\)            
  Postoperative hospital stay (days), Median, SD                                                                               6 ± 2                                              7 ± 15              0.090

Malignant probability was calculated in cases of solid nodule.

Operative time, postoperative complication, and length of hospital stay were analyzed in cases of lobectomy.

GGN, ground‐glass nodule; PET, positron emission tomography; SD, standard deviation.

The flowchart of frozen section diagnosis, clinical diagnosis, and the final pathological diagnoses in each group is shown in Fig [3](#tca13493-fig-0003){ref-type="fig"}. In the FSA group, 15 cases had a benign diagnosis on FSA by wedge resection and did not undergo lobectomy. Of these, the final pathological diagnosis was adenocarcinoma in one case and benign in the remaining 14 cases. The 43 patients with a malignant or equivocal diagnosis (41 and two cases, respectively) on FSA by wedge resection were treated with curative lobectomy. Of these, 3 were benign and the remaining 40 cases were malignant on final pathological diagnosis.

![Flowchart showing the frozen section diagnosis in the frozen section analysis group and clinical diagnosis in the definitive lobectomy group, as well as the final pathological diagnosis in each group.](TCA-11-1996-g003){#tca13493-fig-0003}

In the DL group, seven cases with a benign clinical diagnosis, for whom wedge resection was unsuitable due to the size or depth of the nodule, were treated by lobectomy to confirm pathologically a definitive benign diagnosis. Their final pathological diagnoses were adenocarcinoma in one case and benign in the remaining six cases. The 134 cases in the DL group with a malignant clinical diagnosis were treated with lobectomy, and three of these cases were benign tumor and the remaining 131 cases were malignant on final pathological assessment. There were 43 cases that were feasible for wedge resection but were omitted and assigned to the DL group because of almost certain malignancy according to our algorithm described above, and they all received a final pathological diagnoses of malignancy.

Overall, an error in clinical diagnosis was identified in three cases in the FSA group and four in the DL group, while there were four cases with an error in the FSA by wedge resection. The details of these diagnostic errors are presented in Table [3](#tca13493-tbl-0003){ref-type="table"}.

###### 

Details of errors in clinical and frozen section diagnosis

  Error type                              Sex      Age (years)   Diameter (mm)   Depth (mm)   Uptake of PET   Malignant probability (%)   Clinical diagnosis   Frozen section diagnosis   Final pathological diagnosis
  --------------------------------------- -------- ------------- --------------- ------------ --------------- --------------------------- -------------------- -------------------------- -----------------------------------------------
  Definitive lobectomy group                                                                                                                                                              
  Clinical diagnosis                      Male     53            34              64           Moderate        96                          Malignant                                       Organizing pneumonia
  Clinical diagnosis                      Male     70            35              52           Moderate        94                          Malignant                                       Inflammatory pseudotumor
  Clinical diagnosis                      Female   59            11              45           No uptake       2                           Malignant                                       Localized inflammatory lung disease
  Clinical diagnosis                      Male     40            13              50           Faint           10                          Benign                                          Adenocarcinoma
  Frozen section analysis group                                                                                                                                                           
  Clinical and frozen section diagnosis   Male     78            18              10           Intense         78                          Malignant            Equivocal                  Interstitial pneumonia
  Frozen section diagnosis                Male     70            27              17           Faint           39                          Benign               Malignant                  Necrotic nodules with mycobacterium infection
  Frozen section diagnosis                Male     65            63              63           No PET study    99                          Benign               Equivocal                  Unusual mesenchymal alveolar tumor
  Frozen section diagnosis                Male     79            13              22           No PET study    38                          Malignant            Benign                     Adenocarcinoma
  Clinical diagnosis                      Male     48            22              27           Moderate        77                          Malignant            Benign                     Granulomatous inflammation
  Clinical diagnosis                      Female   76            14              20           No uptake       2                           Malignant            Benign                     Fibrotic scar

Error cases were all solid nodule.

PET, positron emission tomography.

Diagnostic accuracies of clinical and frozen section diagnosis are shown in Table [4](#tca13493-tbl-0004){ref-type="table"}. Both had equivalently high diagnostic accuracy. On subgroup analysis by nodule type (Table [5](#tca13493-tbl-0005){ref-type="table"}), all GGN (pure and part‐solid) cases that were diagnosed clinically malignant were classified as malignant on final pathological diagnoses; the accuracy was 100%. The accuracy of frozen section diagnosis of GGNs was also 100%.

###### 

Diagnostic accuracies of clinical and frozen section diagnosis

                                             Sensitivity (%)   Specificity (%)   Accuracy (%)   Positive predictive value (%)   Negative predictive value (%)
  ------------------------------------------ ----------------- ----------------- -------------- ------------------------------- -------------------------------
  Clinical diagnosis                                                                                                            
  All (*n* = 199)                            99                77                96             97                              95
  Definitive lobectomy group (*n* = 141)     99                67                97             98                              86
  Frozen section analysis group (*n* = 58)   100               82                95             93                              100
  Frozen section diagnosis (*n* = 58)        98                82                93             93                              93

###### 

Diagnostic accuracies of clinical and frozen section diagnosis in each subgroup of nodule type

                                         Sensitivity (%)   Specificity (%)   Accuracy (%)   Positive predictive value (%)   Negative predictive value (%)
  ------------------------------------- ----------------- ----------------- -------------- ------------------------------- -------------------------------
  Pure GGN and part‐solid GGN                                                                                              
  Clinical diagnosis (*n* = 82)                100               N/A             100                     100                             N/A
  Frozen section diagnosis (*n* = 19)          100               N/A             100                     100                             N/A
  Solid nodule                                                                                                             
  Clinical diagnosis (*n* = 117)               99                77               94                     94                              95
  Frozen section diagnosis (*n* = 39)          95                82               90                     88                              93

GGN, ground‐glass nodule.

Discussion {#tca13493-sec-0010}
==========

There were two major findings in this study. The diagnostic accuracy of clinical diagnosis was high and was not inferior to that of frozen section diagnosis, and the accuracies of frozen section and clinical diagnosis for GGN were both 100%.

First, the diagnostic accuracy of clinical diagnosis was high and not inferior to that of frozen section diagnosis in both groups. The FSA group included smaller and less deep nodules and a higher rate of benign clinical diagnosis than the DL group. Based on these factors, FSA by wedge resection was deemed to be feasible and necessary for these patients. Diagnostic accuracy, sensitivity, and specificity between the clinical and frozen section diagnoses were not different in the FSA group. The benign nature of the nodule in the 14 cases with a benign clinical diagnosis was diagnosed by FSA and confirmed by final pathological diagnosis, avoiding unnecessary lobectomy. One patient with a benign frozen section diagnosis had a malignant final pathological diagnosis, and the error was caused by sampling, whereas three cases with a malignant or equivocal frozen section diagnosis had a benign pathological diagnosis, and the error was caused by interpretation. Previous studies reported false‐negative and false‐positive rates of FSA against the paraffin section (final) diagnosis ranging between 1.9%--13.1% and 0%--0.2%, respectively, with a specifically higher false‐negative rate for small nodules (≤1.1 cm in diameter).[9](#tca13493-bib-0009){ref-type="ref"}, [10](#tca13493-bib-0010){ref-type="ref"} Other studies also reported on the errors and pitfalls of FSA.[8](#tca13493-bib-0008){ref-type="ref"}, [17](#tca13493-bib-0017){ref-type="ref"}, [18](#tca13493-bib-0018){ref-type="ref"} Surgeons should be aware of the possibility of these diagnostic errors, even with FSA. The DL group included nodules likely to be almost malignant or larger and deeper nodules that were unsuitable for wedge resection for FSA. For these cases, the accuracy of the clinical diagnosis was high and not inferior to that of frozen section diagnosis and it would be acceptable and reasonable to perform DL without FSA. Previous studies also supported performing DL without preoperative tissue diagnosis and FSA for patients with a high probability of malignant nodules, and this study added information about the accuracy of clinical diagnosis.[13](#tca13493-bib-0013){ref-type="ref"}, [14](#tca13493-bib-0014){ref-type="ref"}, [15](#tca13493-bib-0015){ref-type="ref"} The specificity of the clinical diagnosis was inferior to that of FSA in our study, probably due to the small number of benign nodules on the final diagnosis in the DL group. A small number of lobectomies for nodules with clinical benign diagnosis that were unsuitable for wedge resection due to their size or depth were performed to confirm benign on a final pathological diagnosis.

Second, the diagnostic accuracy of frozen section and clinical diagnosis for GGNs (pure and part‐solid) were 100%. Therefore, GGNs selected carefully with a clinical malignant diagnosis would be enough reason to proceed to definitive resection such as lobectomy or segmentectomy without the need for confirmation of malignancy by FSA. Diagnostic accuracy of FSA by wedge resection was also 100%. However, because of concerns of the possibility of a positive margin in cases of wedge resection for large or deep GGNs with extensive and unclear boundaries, which carry the risk of dissemination,[^12^](#tca13493-bib-0012){ref-type="ref"} these cases should be candidates for lobectomy.

Intraoperative core needle biopsy for FSA provides an alternative method to wedge resection for large or deep nodules, which are unsuitable for wedge resection. Isaka *et al*.[^19^](#tca13493-bib-0019){ref-type="ref"} reported a sensitivity, specificity, and accuracy of 94%, 88%, and 94%, respectively, for a core needle biopsy. However, because FSA using intraoperative core needle biopsy has the possibility for not only diagnostic error but also sampling error due to small and deep lesions, as well as a potential risk of pleural dissemination,[^11^](#tca13493-bib-0011){ref-type="ref"} this procedure was not performed as standard. We noted that four malignant cases (7%) in the wedge resection for FSA had a positive surgical margin. Therefore, the potential risk for pleural dissemination is not negligible and the indications for FSA by wedge resection should be carefully considered including taking the size and depth of the nodule and radiological findings predicting malignancy into consideration.

The limitations of our study should be acknowledged. First, we used a retrospective design, comparing groups with very different backgrounds. The DL group included large and high malignant probability nodules or many GGNs, which would affect the high diagnostic accuracy. Furthermore, because FSA was not performed in all patients, the diagnostic accuracy of frozen section diagnosis was among the patients assigned to the FSA group which included small and low malignant probability nodules or less GGNs. Second, we did not include cases of segmentectomy as an oncologically acceptable resection. However, because oncologically acceptable segmentectomy is generally indicated for GGNs,[20](#tca13493-bib-0020){ref-type="ref"}, [21](#tca13493-bib-0021){ref-type="ref"}, [22](#tca13493-bib-0022){ref-type="ref"}, [23](#tca13493-bib-0023){ref-type="ref"} our results may support oncologically acceptable segmentectomy without intraoperative FSA for GGNs. Third, we did not include wedge resection for GGNs to assess the invasiveness of adenocarcinoma on paraffin section analysis (for final pathological diagnosis) to determine the need for secondary lobectomy later. A recent study reported on the evaluation of invasiveness of adenocarcinoma using FSA.[^24^](#tca13493-bib-0024){ref-type="ref"} If preinvasive adenocarcinoma can be evaluated with high accuracy, the clinical significance of FSA may be beyond benign/malignant judgment.

In conclusion, the accuracies of clinical diagnosis in both groups were high and not inferior to that of frozen section diagnosis by wedge resection in the FSA group. In any case, it is important for surgeons to recognize the possibility of diagnostic error, even with FSA by wedge resection. FSA should be considered for cases likely to be benign to avoid unnecessary lobectomy. Therefore, DL is an acceptable treatment option for large or deep nodules and GGNs selected carefully with malignant clinical diagnosis when performing a preoperative nonsurgical biopsy can expose the patient to unnecessary risks or inadequately lengthen surgical management.
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